Exciting news for LarynxLock!

We have successfully closed our latest investment round with LIOF and three angel investors. Two of them are practicing anesthesiologists, bringing welcomed support and enthusiasm from experts in the field!

LIOF has supported LarynxLock from the very beginning. Starting with a subsidy, followed by a convertible loan, and now this equity investment, they have provided continuous financial backing, valuable connections, and industry knowledge. We’re delighted to have LIOF support our vision for this next chapter.

Building a company from a good idea is a journey filled with highs and lows. Our team has adapted and grown with every challenge we overcame along the way. With this new capital, we are stepping up our commercial expansion. After launching sales in the Netherlands at the end of 2025, we are now expanding across Europe, while international distributors and clinicians worldwide are showing interest.

Anesthesiologists know the challenge of airway leaks during anesthesia, especially in demanding positions like beach chair, ophthalmic, or ear, nose, and throat (ENT) procedures. LarynxLock solves this well-known problem quickly and easily, helping avoid unnecessary intubations while making airway management safer, faster, and more environmentally sustainable.

Thank you to our investors and partners for believing in our mission!

For more information about LarynxLock, go to: www.larynxlock.com